Figure 1.
Selection of study population.
Patients referred to the PCI center for primary PCI by a regionalized STEMI program. Consecutive eligible patients were recruited for serial platelet reactivity testing using the VerifyNow P2Y12 assay.
Table 1.
Baseline characteristics.
Table 2.
Baseline and 48 hour laboratory values.
Figure 2.
Proportion of patients achieving platelet reactivity unit values <208 during the first 48 hours following ticagrelor bolus alone (red bars) or clopidogrel followed by reloading with a ticagrelor bolus (gray bars).
Clopidogrel and ticagrelor co-therapy resulted in more patients achieving target platelet inhibition at 1, 2, 4, and 6 hours following ticagrelor administration.
Table 3.
Platelet reactivity units following ticagrelor administration.